Everything on Healthcare Disruption & Pricing

Direct-to-consumer healthcare platforms are successfully bypassing traditional PBM and insurance networks, forcing an ~80% price reduction on blockbuster drugs like GLP-1s within 18 months.

Impact: Pharmaceutical distribution models will continue shifting toward consumer-direct channels, forcing legacy intermediaries to redefine their value proposition as price transparency becomes the market standard.

— from Hims & Hers CEO on Disrupting Healthcare, AI Integration, and Public Market Strategy · The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch· Apr 04, 2026